Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 21 | SFEBES2009 | Next issue

Society for Endocrinology BES 2010

Symposia

Novel mechanistic insights into thyroid diseases

ea0021s1.1 | Novel mechanistic insights into thyroid diseases | SFEBES2009

Human mutations causing hypothyroidism

Moreno Jose

Hypothyroidism is the most frequent innate endocrine disorder, reaching a prevalence of 1 in 1200 newborns. Defects causing hypothyroidism occur at any level of the hypothalamus-pituitary-thyroid axis, but also at peripheral tissues, where alterations of intracellular transport, deiodination or nuclear action of thyroid hormone have been described in humans.In recent decades, molecular research found evidence that hypothyroidism is a genetic disease. Def...

ea0021s1.2 | Novel mechanistic insights into thyroid diseases | SFEBES2009

Genetic mechanisms defining the response to thyroid hormone replacement

Panicker V

The adequacy of thyroid hormone replacement in hypothyroid subjects has long been debated. A proportion of subjects on thyroxine report not achieving their pre-disease level of well-being and evidence from community studies suggest impaired well-being in subjects on thyroxine compared to the general population. Our work on the large HUNT 2 cohort from Norway confirms this and furthermore revealed that subjects on thyroxine have a different relationship between TSH and well-bei...

ea0021s1.3 | Novel mechanistic insights into thyroid diseases | SFEBES2009

The clinical spectrum of Pendred syndrome

Kopp P

Pendred syndrome (PS) is an autosomal, recessive disorder characterized by sensorineural deafness, goiter, and a positive perchlorate test. PS, one of the most common forms of syndromic deafness, is caused by biallelic mutations in the SLC26A4 gene, which encodes the anion transporter pendrin. Functionally, pendrin can serve as an exchanger of several anions including chloride, bicarbonate and iodide. Pendrin is expressed in the inner ear, the thyroid and the kidney.</p...

ea0021s1.4 | Novel mechanistic insights into thyroid diseases | SFEBES2009

Novel mechanisms regulating the sodium iodide symporter: implications for thyroid tumourigenesis

McCabe Chris

The treatment of thyroid cancer has not changed substantially for several decades, in contrast to most other tumour types. Total thyroidectomy and administration of ablative radioiodine remain the cornerstones of the therapeutic regimen, which is associated with a good 5-year survival rate. Nonetheless, thyroid cancer treatment is not perfect, and several hurdles remain to be overcome. Radioiodine ablation of differentiated thyroid cancers and their metastases utilises the abi...